000 | 01051 a2200277 4500 | ||
---|---|---|---|
005 | 20250517072147.0 | ||
264 | 0 | _c20151231 | |
008 | 201512s 0 0 eng d | ||
022 | _a1176-6336 | ||
024 | 7 |
_a10.2147/TCRM.S94010 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFrankova, Sona | |
245 | 0 | 0 |
_aUSP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study. _h[electronic resource] |
260 |
_bTherapeutics and clinical risk management _c2015 |
||
300 |
_a1853-61 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
700 | 1 | _aJirsa, Milan | |
700 | 1 | _aMerta, Dusan | |
700 | 1 | _aNeroldova, Magdalena | |
700 | 1 | _aUrbanek, Petr | |
700 | 1 | _aSenkerikova, Renata | |
700 | 1 | _aSpicak, Julius | |
700 | 1 | _aSperl, Jan | |
773 | 0 |
_tTherapeutics and clinical risk management _gvol. 11 _gp. 1853-61 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2147/TCRM.S94010 _zAvailable from publisher's website |
999 |
_c25589679 _d25589679 |